Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation ...Middle East

SHANGHAI, Aug. 27, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (Sanyou) and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary monoclonal antibody drug developed by Sanyou, which grants...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation )

Also on site :

• First cargo leaves LNG Canada
• Kendall Jenner’s Venice Getaway Post Draws Sweet Message from Kris Jenner
• Democratic ‘Thinkers’ Already Plotting Project 2029